WO2022131407A1 - Dermis-based artificial skin comprising basement membrane layer and manufacturing method therefor - Google Patents
Dermis-based artificial skin comprising basement membrane layer and manufacturing method therefor Download PDFInfo
- Publication number
- WO2022131407A1 WO2022131407A1 PCT/KR2020/018666 KR2020018666W WO2022131407A1 WO 2022131407 A1 WO2022131407 A1 WO 2022131407A1 KR 2020018666 W KR2020018666 W KR 2020018666W WO 2022131407 A1 WO2022131407 A1 WO 2022131407A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- basement membrane
- membrane layer
- dermis
- skin
- artificial skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
Definitions
- the present invention relates to a dermis-based artificial skin including a basement membrane layer and a method for manufacturing the same.
- the present invention minimizes the retention of cells and immune response-inducing factors in the epidermis and dermal layers, while preserving the basement membrane layer and includes a basement membrane layer that can be applied as artificial skin, and the cell-free dermis It relates to artificial skin prepared by culturing skin-derived cells in the dermis.
- the skin is the largest organ in the human body and plays a primary role in defense against external stimuli and the risk of infection.
- the skin consists of three layers: the epidermis, dermis, and hypodermis. It is an important complex institution that carries out
- Artificial skin is a form in which the dermis substitute and the stratum corneum existing thereon are differentiated. It is also involved in the wound healing process by controlling the formation of the epidermis. Therefore, artificial skin including a basement membrane layer is essential for skin regeneration and alternative tests using artificial skin.
- the currently applied skin substitute is a form of directly applying biocompatible synthetic polymers such as PLGA and bio-derived degradable coating materials such as donated de-epidermal dermis, collagen, gelatin and small intestinal submucosa, or skin-derived collagen or polymer sponge. It is a form in which artificial skin cultured with cells is applied.
- Collagen is a protein that occupies most of the dermal layer of the skin, and although it is marketed in various types of products, the price is high due to difficulties in the manufacturing process. There is a disadvantage that the dermal layer cannot be implemented as it is.
- animal-derived extracellular matrix is coated to form a basement membrane layer and cell adhesion, or culture elements containing animal-derived components (feeder cells, bovine serum, pig trypsin, etc.)
- animal-derived components feeder cells, bovine serum, pig trypsin, etc.
- the structure of the dermal layer including the basement membrane layer and the extracellular matrix, which facilitates the attachment of keratinocytes from the donor skin, is preserved, and an immune response can be generated.
- a cell-free dermis including the removed basement membrane layer is prepared.
- skin-derived cells to the acellular dermis including the basement membrane layer and performing complex culture, a full-thickness artificial skin in which both the dermis and the epidermis exist is provided.
- An object of the present invention is to provide a dermis-based artificial skin including a basement membrane layer and a method for manufacturing the same.
- the present invention provides a cell-free dermis comprising a basement membrane layer that can be applied as artificial skin by minimizing the residual of cells and immune response-inducing factors in the epidermis and dermal layers, while preserving the basement membrane layer, and a method for manufacturing the same. intended to provide
- the present invention provides feeder cell-free, xeno-free and serum-free formulations without coating of other animal-derived extracellular matrix on the cell-free dermis including the freeze-dried basement membrane layer.
- An object of the present invention is to provide an artificial skin prepared by applying skin-derived cells to a culture element and a method for manufacturing the same.
- the present invention comprises the steps of culturing after seeding fibroblasts in the dermal direction of the acellular dermis including the basement membrane layer;
- a method for manufacturing a dermis-based artificial skin including a basement membrane layer comprising the step of seeding keratinocytes on the basement membrane layer of the acellular dermis including the basement membrane layer, followed by culturing and differentiation.
- the present invention is manufactured by the method for manufacturing artificial skin described above,
- an acellular dermal scaffold comprising a basement membrane layer comprising fibroblasts
- a dermis-based artificial skin including a basement membrane layer formed on the basement membrane layer of the acellular dermis including the basement membrane layer, and composed of an epidermis in which keratinocytes are cultured and differentiated.
- the cell-free dermis including the basement membrane layer according to the present invention includes a basement membrane layer that facilitates adhesion of skin-derived cells in its structure and preserves the structure of the dermal layer. Therefore, application and culture of skin-derived cells in culture elements of feeder cell-free, xeno-free and serum-free without requiring additional coating of animal-derived extracellular matrix. / Differentiation is possible and clinically safe can be given.
- the artificial skin prepared by culturing skin-derived cells on the artificial skin support can safely and effectively regenerate tissue when transplanted into a skin defect.
- FIG. 1 shows a process of manufacturing the cell-free dermis including the basement membrane layer having a thin thickness.
- HDF human-derived fibroblasts
- 3(a) shows the results of confirming cell proliferation by culturing fibroblasts in the acellular dermis including the basement membrane layer and the acellular dermis not including the basement membrane layer.
- 3(b) and (c) show the results of confirming cell viability by period by culturing fibroblasts in the acellular dermis (B) including the basement membrane layer and the acellular dermis (C) not including the basement membrane layer.
- FIG. 4(a) shows the results of confirming cell proliferation by culturing keratinocytes (HEK) in the acellular dermis including the basement membrane layer and the acellular dermis not including the basement membrane layer.
- HEK keratinocytes
- Figure 4 (b) shows the results of confirming cell viability by period by culturing keratinocytes after coating CTS and collagen on the acellular dermis including the basement membrane layer.
- Figure 4 (c) shows the results of seeding and culturing different numbers of keratinocytes in the acellular dermis including the basement membrane layer, and confirming the cell survival for each period.
- FIG. 5 shows the results of culturing human skin-derived keratinocytes and fibroblasts together in the acellular dermis including the basement membrane layer and proceeding with skin differentiation
- FIG. 6 shows the differentiation results through histological analysis.
- the present invention comprises the steps of: A) seeding fibroblasts in the dermal direction of the acellular dermis including the basement membrane layer and then culturing; and
- B) It relates to a method for manufacturing a dermis-based artificial skin including a basement membrane layer, comprising the step of seeding and culturing keratinocytes on the basement membrane layer of the acellular dermis including the basement membrane layer.
- feeder cell free, xeno free and serum free without coating of animal-derived extracellular matrix on the cell-free dermis including the basement membrane layer prepared by the manufacturing method according to the present invention.
- the acellular dermis including the basement membrane layer has compatibility and affinity with skin-derived cells, making it suitable for artificial skin. was confirmed.
- artificial skin a dermis-based artificial skin including a basement membrane layer according to the present invention
- step A) and step B) are not limited, and step A) and step B) may be performed sequentially, or step B) and step A) may be performed sequentially, and also, step A ) and B) can be performed simultaneously.
- artificial skin can be prepared by culturing and/or differentiating skin-derived cells in the acellular dermis including the basement membrane layer.
- the acellular dermis including the basement membrane layer is prepared by delipidation and decellularization of the dermis including the basement membrane layer, and is an acellular dermal matrix (ADM).
- ADM acellular dermal matrix
- the acellular dermis including the basement membrane layer may be applied to the same field as the general acellular dermis, and in the present invention may be applied to artificial skin, which is a skin substitute.
- the acellular dermis including the basement membrane layer performs the role of the dermis in artificial skin, and may serve as a support for culturing and/or differentiation of skin-derived cells.
- the cell-free dermis including the basement membrane layer is prepared by a) removing the epidermis from the skin tissue to prepare the dermis including the basement membrane layer having a thickness of 100 to 300 um;
- the skin tissue may be allogeneic or heterogeneous skin tissue.
- the homogeneous refers to a human, and the heterogeneous refers to animals other than humans, ie, mammals such as pigs, cattle, and horses.
- the acellular dermis including the basement membrane layer can be prepared according to the preparation method of the present invention using allogeneic or heterogeneous skin tissue.
- step a) is a step of removing the epidermis from the skin tissue to prepare the dermis including the basement membrane layer with a thickness of 100 to 300 um.
- the skin including the epidermal layer may be excised to a desired thickness using a dermatome, and in particular, may be excised as thin as 300 um or less.
- a thinner dermis can be easily secured.
- the thickness of the dermis including the basement membrane layer may be 100 to 300 um.
- the cell compatibility of the artificial skin support including the basement membrane layer is excellent. If the thickness exceeds 300 um, cell compatibility may decrease, and if it is too thin, it is unsuitable for use as artificial skin, so it is important to control the thickness within the above range.
- the dermis since the dermis includes the basement membrane layer, the adhesion rate of skin-derived cells can be increased, and through this, artificial skin can be easily manufactured.
- step b) is a step of removing the lipid component from the dermis including the basement membrane layer prepared in step a), and the dermis including the basement membrane layer may be de-fatty.
- the delipidation (delipidation) means removing the lipid component from the dermis including the basement membrane layer.
- defatification may be performed using a delipidation solution.
- the delipidation solution may include a polar solvent, a non-polar solvent, or a mixed solvent thereof.
- Water, alcohol, or a mixed solution thereof may be used as the polar solvent, and methanol, ethanol or isopropyl alcohol may be used as the alcohol.
- a mixed solution of isopropyl alcohol (IPA) and hexane may be used as the delipidation solution.
- the mixing ratio of isopropyl alcohol and hexane may be 20:80 to 80:20.
- the treatment time of the delipidation solution may be 1 to 8 hours.
- step c) is a step of removing cells from the dermis including the basement membrane layer from which the lipid component has been removed by step b), and the dermis including the basement membrane layer can be decellularized.
- Decellularization refers to removing other cellular components other than the extracellular matrix from the dermis including the basement membrane layer, for example, a nucleus, a cell membrane, and hexane.
- the dermis including the basement membrane layer that has undergone delipidation and delipidation may be expressed as acellular dermis including the basement membrane layer.
- decellularization can be performed using a decellularization solution.
- a basic solution may be used as the decellularization solution, and specifically, at least one selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonium hydroxide, calcium carbonate, magnesium hydroxide, calcium hydroxide and ammonia may be used.
- sodium hydroxide (NaOH) may be used as a decellularization solution.
- decellularization was performed using a surfactant or enzyme. However, if the enzyme is used, it may damage the dermal layer itself, and if the enzyme remains and is transplanted into the body, it may damage the original tissue of the patient, and in severe cases, there is a problem of causing an immune response.
- the above-mentioned problem can be solved by using a decellularization solution during decellularization, and also has the advantage that there is no cytotoxicity.
- the concentration of the decellularization solution may be 0.05 to 0.5 M. It is easy to remove the cells in the above concentration range.
- the decellularization step may be performed for 30 minutes to 10 hours. Removal of cells in this time range is easy.
- the step of freeze-drying the cell-free dermis including the basement membrane layer may be additionally performed.
- the freeze-drying removes moisture from the acellular dermis including the basement membrane layer, thereby improving the cell adhesion rate to the acellular dermis.
- freeze-drying may be performed at -60 to 90° C. below zero for 2 to 4 days.
- the step of sterilizing the cell-free dermis including the basement membrane layer may be additionally performed.
- sterilization may be performed by irradiating radiation or electron beams, and the irradiation range may be 10 to 30 kGy.
- the cell-free dermis including the basement membrane layer is prepared by the above-described manufacturing method, and the acellular dermis including the basement membrane layer may be composed of the basement membrane layer and the dermis.
- the cell-free dermis including the basement membrane layer minimizes the residual of immune response-inducing factors, while the basement membrane layer is preserved, so it can be suitably used as artificial skin.
- the present invention prepares artificial skin using the acellular dermis including the basement membrane layer prepared by the above-described manufacturing method.
- the basement membrane layer of the skin is composed of components such as collagen, laminin, proteoglycan, and fibronectin, and serves to strongly attach epithelial cells to the tissue below.
- a basement membrane layer that facilitates adhesion of skin-derived cells is included in the structure, and the structure of the dermis is preserved, so additional animal-derived cells No external coating is required.
- the acellular dermis including the basement membrane layer according to the present invention has a thin thickness of 100 to 300 um. Therefore, adhesion and culture efficiency of skin-derived cells can be further improved, and tissue can be safely and effectively regenerated when transplanted into a skin defect.
- step A) and step B) skin-derived cells can be seeded on the acellular dermis including the basement membrane layer without coating of the animal-derived extracellular matrix.
- step A) and step B) may be performed in feeder cell free, xeno free and serum-free culture elements (environment).
- the feeder cell-free, xeno-free and serum-free culture elements are cultured and/or It means that differentiation is performed. Through this, it is possible to manufacture safe artificial skin by solving the problem of contamination of foreign animal-derived substances.
- step A) is a step of seeding and culturing fibroblasts in the dermal direction of the acellular dermis including the basement membrane layer.
- the dermal direction of the acellular dermis including the basement membrane layer refers to the dermis direction on which the basement membrane layer is not formed, and may be expressed as the dermal layer.
- fibroblasts are the main constituent cells of the dermis, and can further strengthen the dermal tissue by secreting the extracellular matrix and growth factors.
- the number of fibroblasts to be seeded may be 1X 10 4 to 1 X 10 6 per cm 2 .
- culturing of fibroblasts may be performed using a growth factor-based culture medium, and specifically, the culture medium may be a xeno-free and serum-free medium. Cultivation may be performed for 1 to 21 days.
- step B) is a step of seeding keratinocytes on the basement membrane layer of the acellular dermis including the basement membrane layer, followed by culturing and differentiation.
- the skin keratinocytes may be adhered to, cultured and differentiated to the acellular dermis including the basement membrane layer to perform the role of the epidermis. That is, in the present invention, it is possible to manufacture a full-thickness artificial skin in which both the dermis and the epidermis exist.
- the number of keratinocytes to be seeded may be 5 X 10 4 to 1 X 10 6 per cm 2 .
- the culturing of keratinocytes may be performed using a keratinocyte culture medium generally used in the art, and specifically, the culture medium is a growth factor-based feeder cell free, It can be xeno free and serum-free media. Cultivation can be performed for 1 to 7 days.
- differentiation may be performed using a keratinocyte differentiation medium generally used in the art, and specifically, the differentiation medium may be a xeno-free and serum-free medium.
- the present invention relates to a dermis-based artificial skin including a basement membrane layer manufactured by the method for manufacturing a dermis-based artificial skin including the basement membrane layer described above.
- the artificial skin according to the present invention comprises: an acellular dermis comprising a basement membrane layer containing fibroblasts; and
- the basement membrane layer of the acellular dermis including the basement membrane layer is formed on the basement membrane layer of the acellular dermis including the basement membrane layer, and may be composed of an epidermis in which keratinocytes are cultured and differentiated.
- the artificial skin according to the present invention can be used as a skin substitute, and specifically, in the field of cosmetic and reconstructive surgery for skin ulcers due to extensive burns, diabetes, etc. or skin damage and accidents, trauma, and depression of skin tissue due to aging. It can be used as a skin substitute.
- Skin tissue (collected from a cadaver donated by a tissue bank for non-profit patient care) was prepared.
- the dermis including the basement membrane layer was obtained by excising 100 to 300 ⁇ m including the epidermis from the skin tissue using a dermatom. After that, it was washed several times with sterile distilled water.
- the dermis including the excised basement membrane layer was treated with a mixed solution of alcohol (IPA) and hexane (Hexane) to remove fat, and sodium hydroxide (NaOH) was treated to remove cells present in the epidermis and dermis (basement membrane layer). inclusion acellular dermis preparation).
- IPA alcohol
- Hexane hexane
- NaOH sodium hydroxide
- Hydrogen peroxide H 2 O 2
- H 2 O 2 Hydrogen peroxide
- the dermis including the basement membrane layer was placed in a culture vessel and the dermal layer was positioned so that the fibroblasts suspended in the culture medium were seeded and cultured in the dermal layer direction to induce the fibroblasts to adhere and proliferate into the dermal layer.
- the basement membrane layer of the acellular dermis, where fibroblasts are growing was turned upside down and keratinocytes were seeded in the direction of the basement membrane layer and cultured for 1-7 days. Thereafter, artificial skin was prepared by inducing differentiation by maintaining it in a keratinocyte differentiation medium and an air-liquid interface (ALI) state for 14 days.
- ALI air-liquid interface
- Example 1 the epidermis and basement membrane layer were removed and 100 to 300 ⁇ m was excised to prepare the dermis not including the basement membrane layer. was prepared.
- An artificial skin was prepared as in (2) of Example 1.
- FIG. 1 shows a process for manufacturing acellular dermis including a thin basement membrane layer and acellular dermis not including a basement membrane layer.
- the dermis including the basement membrane layer (Example 1), 100 to 300 ⁇ m including the epidermis was excised with derma from the donated skin, and 100 to 300 ⁇ m from the donor skin, from which the epidermis and basement membrane layer were removed, derma
- the dermis without the basement membrane layer (Comparative Example 1) excised with a tom
- the acellular dermis including the basement membrane layer and the acellular dermis not including the basement membrane layer were prepared through processes such as fat removal, decellularization and sterilization. .
- the dermis including the basement membrane shows a cell-free dermis including the basement membrane layer, and the dermis without the basement membrane uses the acellular dermis not including the basement membrane layer.
- the cell-free dermis including the basement membrane layer, which had been washed, was prepared in a wet (hydration) state and a dry state by freeze-drying to a thickness of 1 mm or less and 2-3 mm.
- the cell-free dermis including the basement membrane layer used was prepared by the method (1) of Example 1 except for the thickness.
- human dermal fibroblasts human dermal fibroblasts, HDF
- absorbance was measured with CCK-8 Kit on the 7th day of culture to confirm the degree of cell proliferation.
- FIG. 2 is a graph showing the results of confirming cell proliferation by culturing skin-derived fibroblasts in acellular dermis including basement membrane layers having different thicknesses. As shown in FIG. 2, it can be confirmed that the cell adhesion and cell proliferation are very excellent in the lyophilized formulation (dry state) having a thickness of 1 mm or less.
- Example 1 using the dermis including the basement membrane layer prepared in Example 1 and the dermis without the basement membrane layer prepared in Comparative Example 1, coated and uncoated with extracellular matrix components (CTS, collagen), 1X10 per cm 2 A cell suspension containing 5 human skin-derived fibroblasts was sprayed and cultured. In order to confirm cell adhesion and proliferation on the dermal surface, the cells were cultured in a cell incubator for 1, 4, 7, 14, and 21 days of culture.
- CTS extracellular matrix components
- Figure 3 (a) shows the results of confirming the degree of proliferation of fibroblasts in the dermis with/without the basement membrane layer according to the presence or absence of the basement membrane layer.
- Non coating is the dermis with/without the uncoated basement membrane layer
- CTS is the dermis with/without the basement membrane layer coated with CTS
- an extracellular matrix component is the dermis with/without the basement membrane layer coated with the extracellular matrix component, collagen.
- the results of absorbance measurements in the dermis are shown.
- proliferation of fibroblasts can be confirmed in all groups during the culture period, and it can be confirmed that the dermis with the basement membrane has superior cell adhesion than the dermis without the basement membrane.
- human skin-derived fibroblasts were cultured in the dermis with the basement membrane layer prepared in (1) of Example 1 and the dermis without the basement membrane layer prepared in (1) of Comparative Example 1, and cultured for 1 day, 4 days, 7 days.
- Cell adhesion and survival were confirmed with a confocal microscope (LSM 700, Carl Zeiss, Germany) using Live/dead cell viability assay (Life Technology, USA) for 14 days and 21 days.
- Example 1 (1) Cell compatibility for the dermis with/without the basement membrane layer prepared in Example 1 (1) and Comparative Example 1 (1) was confirmed.
- the cell suitability was confirmed by culturing human skin-derived keratinocytes (HEK) on the dermis with/without the basement membrane layer.
- HEK human skin-derived keratinocytes
- the cell suspension containing 1X10 5 keratinocytes per cm 2 is sprayed with and without the extracellular matrix component (CTS, collagen) coated. cultured.
- CTS extracellular matrix component
- the cells were cultured in a cell culture medium for a certain period of time.
- Cell compatibility analysis was performed as follows. On the 1st, 3rd, and 7th days, the absorbance was measured with the CCK-8 kit to confirm the degree of cell proliferation.
- Non coating shows the absorbance measurement results in a state in which the dermis with/without basement membrane layer is not coated, CTS is in a state in which CTS, an extracellular matrix component, is coated, and Collagen is in a state in which collagen, an extracellular matrix component, is coated. .
- keratinocytes were cultured in the dermis including the basement membrane layer prepared in Example 1, and cell adhesion and survival were observed using Live/dead cell viability assay (Life Technology, USA) on the 1st, 4th, and 7th days of culture. was confirmed with a confocal microscope (LSM 700, Carl Zeiss, Germany).
- the dermis including the basement membrane was not coated or coated with an extracellular matrix (CTS, collagen).
- CTS extracellular matrix
- Figure 4(b) shows the results of confirming cell survival (specifically, cell adhesion and cell proliferation) by period by culturing keratinocytes in the dermis including the basement membrane layer.
- cell survival specifically, cell adhesion and cell proliferation
- green indicates living cells
- red indicates dead cells.
- 4( c ) shows the results of seeding and culturing different numbers of keratinocytes in the dermis including the basement membrane layer and confirming the cell survival for each period. In this case, green indicates living cells and red indicates dead cells.
- keratinocytes proliferate according to the number of cells in the dermis including the basement membrane layer.
- the dermis including the basement membrane has compatibility and affinity with skin-derived cells.
- Example 1 (1) Using the dermis including the basement membrane layer prepared in Example 1 (1), fibroblasts labeled with DiO in the direction of the dermis were seeded and cultured, and keratinocytes labeled with DiI indicating red on the basement membrane layer were harvested. After seeding, culture was performed, and cell adhesion and morphology were confirmed after 1 day of culture.
- keratinocytes were seeded in the direction of the basement membrane layer and cultured, and then maintained in a keratinocyte differentiation medium and ALI (air-liquid interface) state for 14 days. differentiation was induced. Through this, artificial skin was manufactured.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 기저막층을 포함하는 진피 기반 인공 피부 및 그 제조방법에 관한 것이다. The present invention relates to a dermis-based artificial skin including a basement membrane layer and a method for manufacturing the same.
더욱 상세하게는, 본 발명은 표피 및 진피층의 세포 및 면역반응 유발 인자의 잔류를 최소화한 반면, 기저막층은 보존하여 인공 피부로 적용할 수 있는 기저막층을 포함하는 무세포 진피, 및 상기 무세포 진피에 피부유래 세포를 배양하여 제조된 인공 피부에 관한 것이다. More specifically, the present invention minimizes the retention of cells and immune response-inducing factors in the epidermis and dermal layers, while preserving the basement membrane layer and includes a basement membrane layer that can be applied as artificial skin, and the cell-free dermis It relates to artificial skin prepared by culturing skin-derived cells in the dermis.
피부는 인체에서 가장 큰 장기로, 외부 자극 및 감염 위험으로부터 일차적인 방어 역할을 담당한다. 피부는 표피(epidermis), 진피(dermis), 피하조직(hypodermis)의 3개 층으로 구성되며, 모낭, 털, 땀샘, 피지선 등과 같은 부속 기관이 있어 보호막 기능 외에도 피부 탄력, 체온 조절 등의 다양한 기능을 수행하고 있는 중요한 복합 기관이다.The skin is the largest organ in the human body and plays a primary role in defense against external stimuli and the risk of infection. The skin consists of three layers: the epidermis, dermis, and hypodermis. It is an important complex institution that carries out
광범위한 화상, 당뇨병 등으로 인한 피부궤양 또는 피부 손상과 사고, 외상, 노화 등으로 인한 피부 조직의 함몰 등에 대한 미용성형 및 재건성형 분야에서 대체 피부의 필요성이 증가됨에 따라, 피부를 대신할 수 있는 생체 재료 및 인공 피부 개발이 급속도로 진행되어 왔으며, 최근에는 이를 넘어 화장품 개발시의 동물실험 대체시험이나, 신약 개발에서 사용되는 화합물의 독성시험으로 그 적용이 확대되고 있다.As the need for replacement skin increases in the field of cosmetic surgery and reconstructive surgery for skin ulcers caused by extensive burns, diabetes, or skin damage and skin tissue dents due to accidents, trauma, aging, etc., a living body that can replace the skin The development of materials and artificial skin has been rapidly progressing, and recently, its application is expanding beyond this to alternative tests for animal testing in cosmetic development or toxicity tests for compounds used in new drug development.
인공 피부는 진피 대용물과 그 위에 존재하는 각질층까지 분화시킨 형태로, 진피와 각질층 사이의 기저막층은 두 층 사이의 물리적인 방어막일뿐만 아니라, 표피세포의 부착을 용이하게 하여 지지대로서 역할을 하고, 표피의 형성을 조절하여 상처치유과정에도 관여한다. 그러므로, 기저막층이 포함된 인공 피부는 피부 재생 및 인공 피부를 이용한 대체 시험에서도 필수적이다.Artificial skin is a form in which the dermis substitute and the stratum corneum existing thereon are differentiated. It is also involved in the wound healing process by controlling the formation of the epidermis. Therefore, artificial skin including a basement membrane layer is essential for skin regeneration and alternative tests using artificial skin.
현재 적용되는 피부 대체재는 공여받은 탈표피화된 진피, 콜라겐, 젤라틴 및 소장점막하조직과 같은 생체 유래 분해성 피복제와 PLGA와 같은 생체친화성 합성 고분자를 직접 적용한 형태이거나, 콜라겐이나 고분자 스폰지에 피부 유래 세포를 배양한 인공 피부를 적용한 형태이다.The currently applied skin substitute is a form of directly applying biocompatible synthetic polymers such as PLGA and bio-derived degradable coating materials such as donated de-epidermal dermis, collagen, gelatin and small intestinal submucosa, or skin-derived collagen or polymer sponge. It is a form in which artificial skin cultured with cells is applied.
콜라겐은 피부 진피층의 대부분을 차지하는 단백질로써, 다양한 형태의 제품으로 시판되고 있지만, 제조 공정상의 어려움으로 가격이 높게 형성되며, 특히, 콜라겐을 인공 피부 지지체로 사용한 경우, 세포와 혼합 후 수축되는 단점과 진피층을 그대로 구현할 수 없다는 단점이 있다.Collagen is a protein that occupies most of the dermal layer of the skin, and although it is marketed in various types of products, the price is high due to difficulties in the manufacturing process. There is a disadvantage that the dermal layer cannot be implemented as it is.
또한, 피부 유래 세포가 배양된 대체재 혹은 인공 피부 제작시 기저막층 형성 및 세포 부착을 위해 동물 유래 세포외기질을 코팅하거나, 동물 유래 성분(피더세포, 우혈청, 돼지 트립신 등)이 포함된 배양 요소로 세포를 배양하여 외래성 바이러스 및 마이코플라스마 오염 등과 같은 안전성에 문제가 있을 수 있다.In addition, when manufacturing a substitute material or artificial skin in which skin-derived cells are cultured, animal-derived extracellular matrix is coated to form a basement membrane layer and cell adhesion, or culture elements containing animal-derived components (feeder cells, bovine serum, pig trypsin, etc.) There may be problems with safety such as contamination with adventitious viruses and mycoplasma by culturing cells.
상기 언급한 기존 재료의 한계점을 해결하기 위해, 본 발명에서는 공여받은 피부로부터 각질형성세포의 부착을 용이하게 하는 기저막층과 세포외기질을 포함하는 진피층의 구조는 보존하고, 면역 반응을 일으킬 수 있는 세포 등은 제거한 기저막층을 포함하는 무세포 진피를 제작한다. 또한, 상기 기저막층을 포함하는 무세포 진피에 피부유래 세포를 적용하여 복합 배양함으로써 진피와 표피층이 모두 존재하는 전층 인공 피부를 제공한다. In order to solve the above-mentioned limitations of the existing materials, in the present invention, the structure of the dermal layer including the basement membrane layer and the extracellular matrix, which facilitates the attachment of keratinocytes from the donor skin, is preserved, and an immune response can be generated. A cell-free dermis including the removed basement membrane layer is prepared. In addition, by applying skin-derived cells to the acellular dermis including the basement membrane layer and performing complex culture, a full-thickness artificial skin in which both the dermis and the epidermis exist is provided.
[선행기술문헌][Prior art literature]
[특허문헌][Patent Literature]
1. 한국등록특허 제10-0791502호1. Korean Patent No. 10-0791502
본 발명은 기저막층을 포함하는 진피 기반 인공 피부 및 그의 제조방법을 제공하는 것을 목적으로 한다. An object of the present invention is to provide a dermis-based artificial skin including a basement membrane layer and a method for manufacturing the same.
더욱 상세하게는, 본 발명은 표피와 진피층의 세포 및 면역반응 유발 인자의 잔류를 최소화한 반면, 기저막층은 보존하여 인공 피부로 적용할 수 있는 기저막층을 포함하는 무세포 진피 및 그 제조방법을 제공하는 것을 목적으로 한다.More specifically, the present invention provides a cell-free dermis comprising a basement membrane layer that can be applied as artificial skin by minimizing the residual of cells and immune response-inducing factors in the epidermis and dermal layers, while preserving the basement membrane layer, and a method for manufacturing the same. intended to provide
또한, 본 발명은 상기 동결건조된 기저막층을 포함하는 무세포 진피에 다른 동물 유래 세포외기질의 코팅없이 무영양세포(feeder cell free), 무이종(xeno free) 및 무혈청(serum-free)의 배양 요소에서 피부유래 세포를 적용하여 제조한 인공 피부 및 그 제조방법을 제공하는 것을 목적으로 한다. In addition, the present invention provides feeder cell-free, xeno-free and serum-free formulations without coating of other animal-derived extracellular matrix on the cell-free dermis including the freeze-dried basement membrane layer. An object of the present invention is to provide an artificial skin prepared by applying skin-derived cells to a culture element and a method for manufacturing the same.
본 발명은 기저막층을 포함하는 무세포 진피의 진피 방향에 섬유아세포를 파종한 후 배양하는 단계; 및The present invention comprises the steps of culturing after seeding fibroblasts in the dermal direction of the acellular dermis including the basement membrane layer; and
기저막층을 포함하는 무세포 진피의 기저막층 상에 각질형성세포를 파종한 후 배양 및 분화하는 단계를 포함하는, 기저막층을 포함하는 진피 기반 인공 피부의 제조 방법을 제공한다. Provided is a method for manufacturing a dermis-based artificial skin including a basement membrane layer, comprising the step of seeding keratinocytes on the basement membrane layer of the acellular dermis including the basement membrane layer, followed by culturing and differentiation.
또한, 본 발명은 전술한 인공 피부의 제조 방법에 의해 제조되며,In addition, the present invention is manufactured by the method for manufacturing artificial skin described above,
섬유아세포를 포함하는 기저막층을 포함하는 무세포 진피 지지체; 및an acellular dermal scaffold comprising a basement membrane layer comprising fibroblasts; and
상기 기저막층을 포함하는 무세포 진피의 기저막층 상에 형성되며, 각질형성세포가 배양 및 분화된 표피로 구성되는, 기저막층을 포함하는 진피 기반 인공 피부를 제공한다. It provides a dermis-based artificial skin including a basement membrane layer formed on the basement membrane layer of the acellular dermis including the basement membrane layer, and composed of an epidermis in which keratinocytes are cultured and differentiated.
본 발명에 따른 기저막층을 포함하는 무세포 진피는 그 구조 내에 피부유래 세포의 부착을 용이하게 하는 기저막층이 포함되어 있고 진피층의 구조가 보존되어 있다. 따라서, 추가의 동물유래 세포외기질의 코팅을 필요로 하지 않고, 무영양세포(feeder cell free), 무이종(xeno free) 및 무혈청(serum-free)의 배양 요소에서 피부유래 세포의 적용 및 배양/분화가 가능하며 임상적으로도 안전함을 부여할 수 있다.The cell-free dermis including the basement membrane layer according to the present invention includes a basement membrane layer that facilitates adhesion of skin-derived cells in its structure and preserves the structure of the dermal layer. Therefore, application and culture of skin-derived cells in culture elements of feeder cell-free, xeno-free and serum-free without requiring additional coating of animal-derived extracellular matrix. / Differentiation is possible and clinically safe can be given.
또한, 상기 인공 피부 지지체 상에 피부유래 세포를 배양하여 제조한 인공 피부는 피부 결손부에 이식 시 조직이 안전하고 효과적으로 재생될 수 있다.In addition, the artificial skin prepared by culturing skin-derived cells on the artificial skin support can safely and effectively regenerate tissue when transplanted into a skin defect.
도 1은 얇은 두께 형태의 기저막층을 포함하는 무세포 진피를 제작하는 공정을 나타낸다. 1 shows a process of manufacturing the cell-free dermis including the basement membrane layer having a thin thickness.
도 2는 두께가 상이한 기저막층을 포함하는 무세포 진피에 사람 유래 섬유아세포(HDF)를 배양하여 세포 증식을 확인한 결과를 나타낸다. 2 shows the results of confirming cell proliferation by culturing human-derived fibroblasts (HDF) in acellular dermis including basement membrane layers having different thicknesses.
도 3(a)는 기저막층을 포함하는 무세포 진피 및 기저막층을 포함하지 않는 무세포 진피에 섬유아세포를 배양하여 세포 증식을 확인한 결과를 나타낸다. 3(a) shows the results of confirming cell proliferation by culturing fibroblasts in the acellular dermis including the basement membrane layer and the acellular dermis not including the basement membrane layer.
도 3(b) 및 (c)는 기저막층을 포함하는 무세포 진피(B) 및 기저막층을 포함하지 않는 무세포 진피(C)에 섬유아세포를 배양하여 기간별로 세포 생존을 확인한 결과를 나타낸다. 3(b) and (c) show the results of confirming cell viability by period by culturing fibroblasts in the acellular dermis (B) including the basement membrane layer and the acellular dermis (C) not including the basement membrane layer.
도 4(a)는 기저막층을 포함하는 무세포 진피 및 기저막층을 포함하지 않는 무세포 진피에 각질형성세포(HEK)를 배양하여 세포 증식을 확인한 결과를 나타낸다. 4(a) shows the results of confirming cell proliferation by culturing keratinocytes (HEK) in the acellular dermis including the basement membrane layer and the acellular dermis not including the basement membrane layer.
도 4는 (b)는 기저막층을 포함하는 무세포 진피에 CTS와 콜라겐을 코팅한 후, 각질형성세포를 배양하여 기간별 세포 생존을 확인한 결과를 나타낸다. Figure 4 (b) shows the results of confirming cell viability by period by culturing keratinocytes after coating CTS and collagen on the acellular dermis including the basement membrane layer.
도 4는 (c)는 기저막층을 포함하는 무세포 진피에 각질형성세포의 수를 다르게 파종하여 배양하고 기간별 세포 생존을 확인한 결과를 나타낸다. Figure 4 (c) shows the results of seeding and culturing different numbers of keratinocytes in the acellular dermis including the basement membrane layer, and confirming the cell survival for each period.
도 5는 기저막층을 포함하는 무세포 진피에 사람 피부유래 각질형성세포와 섬유아세포를 함께 배양하고 피부 분화를 진행한 결과를 나타내며, 도 6은 조직학적 분석을 통한 분화 결과를 나타낸다.5 shows the results of culturing human skin-derived keratinocytes and fibroblasts together in the acellular dermis including the basement membrane layer and proceeding with skin differentiation, and FIG. 6 shows the differentiation results through histological analysis.
본 발명은 A) 기저막층을 포함하는 무세포 진피의 진피 방향에 섬유아세포를 파종한 후 배양하는 단계; 및The present invention comprises the steps of: A) seeding fibroblasts in the dermal direction of the acellular dermis including the basement membrane layer and then culturing; and
B) 기저막층을 포함하는 무세포 진피의 기저막층 상에 각질형성세포를 파종한 후 배양하는 단계를 포함하는, 기저막층을 포함하는 진피 기반 인공 피부의 제조 방법에 관한 것이다. B) It relates to a method for manufacturing a dermis-based artificial skin including a basement membrane layer, comprising the step of seeding and culturing keratinocytes on the basement membrane layer of the acellular dermis including the basement membrane layer.
본 발명의 실시예에서는 본 발명에 따른 제조 방법으로 제작된 기저막층을 포함하는 무세포 진피에 동물유래 세포외기질의 코팅 없이 무영양세포(feeder cell free), 무이종(xeno free) 및 무혈청(serum-free) 배양 요소에서 피부유래 세포인 섬유아세포 및/또는 각질형성세포를 파종 및 배양하여, 상기 기저막층을 포함하는 무세포 진피가 피부유래 세포와 적합성과 친화성이 있어 인공 피부로 적합함을 확인하였다. In an embodiment of the present invention, feeder cell free, xeno free and serum free without coating of animal-derived extracellular matrix on the cell-free dermis including the basement membrane layer prepared by the manufacturing method according to the present invention. By seeding and culturing skin-derived fibroblasts and/or keratinocytes in serum-free culture elements, the acellular dermis including the basement membrane layer has compatibility and affinity with skin-derived cells, making it suitable for artificial skin. was confirmed.
이하, 본 발명에 따른 기저막층을 포함하는 진피 기반 인공 피부(이하, 인공 피부라 할 수 있다.)의 제조 방법을 보다 상세하게 설명한다. Hereinafter, a method for manufacturing a dermis-based artificial skin (hereinafter, referred to as artificial skin) including a basement membrane layer according to the present invention will be described in more detail.
본 발명에서 단계 A) 및 단계 B)의 수행 순서는 제한되지 않으며, 단계 A) 및 단계 B)를 순차적으로 수행하거나, 단계 B) 및 단계 A)를 순차적으로 수행할 수 있으며, 또한, 단계 A) 및 B)를 동시에 수행할 수 있다. In the present invention, the order of performing step A) and step B) is not limited, and step A) and step B) may be performed sequentially, or step B) and step A) may be performed sequentially, and also, step A ) and B) can be performed simultaneously.
본 발명에서 인공 피부는 기저막층을 포함하는 무세포 진피에 피부유래 세포를 배양 및/또는 분화하여 제조할 수 있다. In the present invention, artificial skin can be prepared by culturing and/or differentiating skin-derived cells in the acellular dermis including the basement membrane layer.
본 발명에서 기저막층을 포함하는 무세포 진피는 기저막층을 포함하는 진피를 탈지질화 및 탈세포화하여 제조한 것으로서, 무세포 진피(Acellular Dermal Matrix, ADM)이다. In the present invention, the acellular dermis including the basement membrane layer is prepared by delipidation and decellularization of the dermis including the basement membrane layer, and is an acellular dermal matrix (ADM).
상기 기저막층을 포함하는 무세포 진피는 일반적인 무세포 진피와 동일한 분야에 적용될 수 있으며, 본 발명에서는 피부 대체재인 인공 피부에 적용될 수 있다. 구체적으로, 기저막층을 포함하는 무세포 진피는 인공 피부에서 진피의 역할을 수행하며, 피부유래 세포의 배양 및/또는 분화를 위한 지지체의 역할을 수행할 수 있다. The acellular dermis including the basement membrane layer may be applied to the same field as the general acellular dermis, and in the present invention may be applied to artificial skin, which is a skin substitute. Specifically, the acellular dermis including the basement membrane layer performs the role of the dermis in artificial skin, and may serve as a support for culturing and/or differentiation of skin-derived cells.
이러한 기저막층을 포함하는 무세포 진피는 a) 피부 조직에서 표피를 제거하여, 100 내지 300 um 두께의 기저막층을 포함하는 진피를 제조하는 단계; The cell-free dermis including the basement membrane layer is prepared by a) removing the epidermis from the skin tissue to prepare the dermis including the basement membrane layer having a thickness of 100 to 300 um;
b) 상기 기저막층을 포함하는 진피에서 지질 성분을 제거하는 단계; 및b) removing the lipid component from the dermis comprising the basement membrane layer; and
c) 상기 지질 성분이 제거된 기저막층을 포함하는 진피에서 세포를 제거하는 단계를 통해 제조할 수 있다. c) it can be prepared through the step of removing cells from the dermis including the basement membrane layer from which the lipid component has been removed.
본 발명에서 피부 조직은 동종 또는 이종의 피부 조직일 수 있다. 상기 동종은 인간을 의미하며, 이종은 인간 이외의 동물, 즉, 돼지, 소, 말 등의 포유류를 의미할 수 있다.In the present invention, the skin tissue may be allogeneic or heterogeneous skin tissue. The homogeneous refers to a human, and the heterogeneous refers to animals other than humans, ie, mammals such as pigs, cattle, and horses.
즉, 본 발명에서는 동종 또는 이종 유래의 피부 조직을 사용하여 본 발명의 제조 방법에 따라 기저막층 포함 무세포 진피를 제조할 수 있다.That is, in the present invention, the acellular dermis including the basement membrane layer can be prepared according to the preparation method of the present invention using allogeneic or heterogeneous skin tissue.
본 발명에서 단계 a)는 피부 조직에서 표피를 제거하여, 100 내지 300 um 두께의 기저막층을 포함하는 진피를 제조하는 단계이다. In the present invention, step a) is a step of removing the epidermis from the skin tissue to prepare the dermis including the basement membrane layer with a thickness of 100 to 300 um.
일 구체예에서, 상기 단계는 표피층을 포함하는 피부를 더마톰(dermatome)을 이용하여 원하는 두께로 절제할 수 있으며, 특히, 300 um 이하로 얇게 절제할 수 있다. 또한, 표피층을 포함하는 피부를 얇게 얻은 상태에서 표피층만을 제거함으로써 더 얇은 진피를 용이하게 확보할 수 있다.In one embodiment, in the step, the skin including the epidermal layer may be excised to a desired thickness using a dermatome, and in particular, may be excised as thin as 300 um or less. In addition, by removing only the epidermal layer in a state in which the skin including the epidermal layer is thinly obtained, a thinner dermis can be easily secured.
일 구체예에서, 기저막층을 포함하는 진피의 두께는 100 내지 300 um일 수 있다. 상기 두께 범위에서 기저막층 포함 인공 피부 지지체의 세포 적합성 등이 우수하다. 두께가 300 um를 초과하면 세포 적합성이 저하될 우려가 있으며, 너무 얇으면 인공 피부로의 사용에 부적합하므로, 상기 범위로 두께를 조절하는 것이 중요하다. In one embodiment, the thickness of the dermis including the basement membrane layer may be 100 to 300 um. In the above thickness range, the cell compatibility of the artificial skin support including the basement membrane layer is excellent. If the thickness exceeds 300 um, cell compatibility may decrease, and if it is too thin, it is unsuitable for use as artificial skin, so it is important to control the thickness within the above range.
본 발명에서는 진피가 기저막층을 포함하므로, 피부유래 세포의 부착율을 높일 수 있으며, 이를 통해 인공 피부를 용이하게 제작할 수 있다. In the present invention, since the dermis includes the basement membrane layer, the adhesion rate of skin-derived cells can be increased, and through this, artificial skin can be easily manufactured.
본 발명에서 단계 b)는 단계 a)에서 제조된 기저막층을 포함하는 진피에서 지질 성분을 제거하는 단계로, 기저막층을 포함하는 진피를 탈지방화할 수 있다. 상기 탈지방화(delipidation)는 기저막층을 포함하는 진피로부터 지질 성분을 제거하는 것을 의미한다.In the present invention, step b) is a step of removing the lipid component from the dermis including the basement membrane layer prepared in step a), and the dermis including the basement membrane layer may be de-fatty. The delipidation (delipidation) means removing the lipid component from the dermis including the basement membrane layer.
일 구체예에서, 탈지방화는 탈지질 용액을 사용하여 수행할 수 있다. 상기 탈지질 용액은 극성 용매, 비극성 용매 또는 이들의 혼합 용매를 포함할 수 있다. 상기 극성 용매로는 물, 알코올 또는 이들의 혼합 용액을 사용할 수 있으며, 알코올로는 메탄올, 에탄올 또는 이소프로필 알코올을 사용할 수 있다. 또한, 비극성 용매로는 헥산, 헵탄, 옥탄, 또는 이들의 혼합 용액을 사용할 수 있다. 구체적으로, 본 발명에서는 탈지질 용액으로 이소프로필 알코올(IPA) 및 헥산(Hexane)의 혼합 용액을 사용할 수 있다. 이때, 이소프로필 알코올 및 헥산의 혼합 비율은 20:80 내지 80:20일 수 있다. In one embodiment, defatification may be performed using a delipidation solution. The delipidation solution may include a polar solvent, a non-polar solvent, or a mixed solvent thereof. Water, alcohol, or a mixed solution thereof may be used as the polar solvent, and methanol, ethanol or isopropyl alcohol may be used as the alcohol. In addition, as the non-polar solvent, hexane, heptane, octane, or a mixed solution thereof may be used. Specifically, in the present invention, a mixed solution of isopropyl alcohol (IPA) and hexane may be used as the delipidation solution. At this time, the mixing ratio of isopropyl alcohol and hexane may be 20:80 to 80:20.
상기 탈지질 용액의 처리 시간은 1 내지 8 시간일 수 있다. The treatment time of the delipidation solution may be 1 to 8 hours.
본 발명에서 단계 c)는 단계 b)에 의해 지질 성분이 제거된 기저막층을 포함하는 진피에서 세포를 제거하는 단계로, 기저막층을 포함하는 진피를 탈세포화할 수 있다. 탈세포화(decellularization)는 기저막층을 포함하는 진피로부터 세포외기질을 제외한 다른 세포 성분, 예를 들면 핵, 세포막, 헥산 등을 제거하는 것을 의미한다. 본 발명에서는 탈지방화 및 탈지질화를 거친 기저막층을 포함하는 진피를 기저막층을 포함하는 무세포 진피로 표현할 수 있다. In the present invention, step c) is a step of removing cells from the dermis including the basement membrane layer from which the lipid component has been removed by step b), and the dermis including the basement membrane layer can be decellularized. Decellularization refers to removing other cellular components other than the extracellular matrix from the dermis including the basement membrane layer, for example, a nucleus, a cell membrane, and hexane. In the present invention, the dermis including the basement membrane layer that has undergone delipidation and delipidation may be expressed as acellular dermis including the basement membrane layer.
일 구체예에서, 탈세포화는 탈세포 용액을 사용하여 수행할 수 있다. 상기 탈세포 용액으로 염기성 용액을 사용할 수 있으며, 구체적으로, 수산화나트륨, 수산화칼륨, 수산화암모늄, 칼슘카보네이트, 수산화마그네슘, 수산화칼슘 및 암모니아로 이루어진 그룹으로부터 선택된 하나 이상을 사용할 수 있다. 본 발명에서는 탈세포 용액으로 수산화나트륨(NaOH)을 사용할 수 있다. 종래에는 계면활성제 또는 효소를 사용하여 탈세포화를 수행하였다. 그러나, 효소를 사용하는 경우 진피층 자체에 손상을 줄 수 있고, 효소가 잔류하여 체내에 이식되는 경우 환자의 본래 조직에 손상을 줄 수 있으며 심각한 경우엔 면역반응을 일으키는 문제가 있었다. 또한, 계면활성제를 사용하는 경우 상기 계면활성제의 잔류를 최소화시키기 위해 세척 작업이 필요하며, 계면활성제의 잔류는 체내에서 세포 및 조직 독성을 나타내는 원인이 될 수 있었다. 따라서, 본 발명에서는 탈세포화시 탈세포 용액을 사용하여 전술한 문제점을 해결할 수 있으며, 또한, 세포 독성이 없다는 장점을 가진다. In one embodiment, decellularization can be performed using a decellularization solution. A basic solution may be used as the decellularization solution, and specifically, at least one selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonium hydroxide, calcium carbonate, magnesium hydroxide, calcium hydroxide and ammonia may be used. In the present invention, sodium hydroxide (NaOH) may be used as a decellularization solution. Conventionally, decellularization was performed using a surfactant or enzyme. However, if the enzyme is used, it may damage the dermal layer itself, and if the enzyme remains and is transplanted into the body, it may damage the original tissue of the patient, and in severe cases, there is a problem of causing an immune response. In addition, when a surfactant is used, a washing operation is required to minimize the residue of the surfactant, and the residue of the surfactant may cause toxicity to cells and tissues in the body. Therefore, in the present invention, the above-mentioned problem can be solved by using a decellularization solution during decellularization, and also has the advantage that there is no cytotoxicity.
일 구체예에서, 탈세포 용액의 농도는 0.05 내지 0.5 M일 수 있다. 상기 농도 범위에서 세포의 제거가 용이하다. In one embodiment, the concentration of the decellularization solution may be 0.05 to 0.5 M. It is easy to remove the cells in the above concentration range.
또한, 일 구체예에서, 탈세포화 단계는 30 분 내지 10 시간 동안 수행될 수 있다. 상기 시간 범위에서 세포의 제거가 용이하다.Also, in one embodiment, the decellularization step may be performed for 30 minutes to 10 hours. Removal of cells in this time range is easy.
또한, 본 발명에서는 기저막층 포함 무세포 진피를 동결 건조하는 단계를 추가로 수행할 수 있다. 상기 동결건조를 통해 기저막층을 포함하는 무세포 진피의 수분을 제거하며, 이를 통해 상기 무세포 진피에의 세포 부착율을 향상시킬 수 있다. In addition, in the present invention, the step of freeze-drying the cell-free dermis including the basement membrane layer may be additionally performed. The freeze-drying removes moisture from the acellular dermis including the basement membrane layer, thereby improving the cell adhesion rate to the acellular dermis.
일 구체예에서 동결건조는 영하 60 내지 90℃에서 2 내지 4일 동안 수행할 수 있다. In one embodiment, freeze-drying may be performed at -60 to 90° C. below zero for 2 to 4 days.
또한, 본 발명에서는 기저막층을 포함하는 무세포 진피를 멸균하는 단계를 추가로 수행할 수 있다. In addition, in the present invention, the step of sterilizing the cell-free dermis including the basement membrane layer may be additionally performed.
일 구체예에서, 멸균은 방사선 혹은 전자선을 조사하여 수행할 수 있으며, 조사 범위는 10 내지 30 kGy일 수 있다.In one embodiment, sterilization may be performed by irradiating radiation or electron beams, and the irradiation range may be 10 to 30 kGy.
전술한 제조 방법에 의해 기저막층을 포함하는 무세포 진피가 제조되며, 상기 기저막층을 포함하는 무세포 진피는 기저막층 및 진피로 구성될 수 있다. 상기 기저막층을 포함하는 무세포 진피는 면역반응 유발 인자의 잔류를 최소화한 반면, 기저막층이 보존되어 있으므로 인공 피부로 적합하게 사용할 수 있다.The cell-free dermis including the basement membrane layer is prepared by the above-described manufacturing method, and the acellular dermis including the basement membrane layer may be composed of the basement membrane layer and the dermis. The cell-free dermis including the basement membrane layer minimizes the residual of immune response-inducing factors, while the basement membrane layer is preserved, so it can be suitably used as artificial skin.
본 발명은 전술한 제조 방법에 의해 제조된 기저막층을 포함하는 무세포 진피를 사용하여 인공 피부를 제조한다. The present invention prepares artificial skin using the acellular dermis including the basement membrane layer prepared by the above-described manufacturing method.
세포가 포함된 대체재 혹은 인공 피부 모델의 제작시, 전통적으로 동물유래 성분이 포함된 배양 요소로 세포를 배양하거나 동물유래 세포외기질을 코팅하여 제작하며, 동물유래 성분의 부재 시 세포 부착 및 분화가 일어나지 않는다(Lamb R, Ambler CA (2013) Keratinocytes Propagated in Serum-Free, Feeder-Free Culture Conditions Fail to Form Stratified Epidermis in a Reconstituted Skin Model. PLoS ONE 8(1): e52494. doi:10.1371/journal.pone.0052494). 그러나, 이러한 동물유래 성분을 사용할 경우 동물유래 바이러스나 마이코플라스마 등과 같은 오염을 일으킬 수 있어 안전성에 문제가 될 수 있다. When manufacturing substitutes or artificial skin models containing cells, traditionally, cells are cultured with culture elements containing animal-derived ingredients or manufactured by coating animal-derived extracellular matrix. (Lamb R, Ambler CA (2013) Keratinocytes Propagated in Serum-Free, Feeder-Free Culture Conditions Fail to Form Stratified Epidermis in a Reconstituted Skin Model. PLoS ONE 8(1): e52494. doi:10.1371/journal.pone .0052494). However, when such animal-derived ingredients are used, they may cause contamination such as animal-derived viruses or mycoplasma, which may pose a safety problem.
피부의 기저막층은 콜라겐, 라미닌, 프로테오글리칸, 피브로넥틴 등과 같은 성분으로 구성되어 상피세포를 그 아래 조직에 강하게 부착시키는 역할을 한다.The basement membrane layer of the skin is composed of components such as collagen, laminin, proteoglycan, and fibronectin, and serves to strongly attach epithelial cells to the tissue below.
따라서, 본 발명에서는 기저막층을 포함하는 무세포 진피를 사용하므로, 그 구조 내에 피부유래 세포의 부착을 용이하게 하는 기저막층이 포함되어 있고, 또한 진피의 구조가 보존되어 있으므로, 추가의 동물유래 세포외기질의 코팅을 필요로 하지 않는다. 이를 통해, 기저막층을 포함하는 무세포 진피 상에서 피부유래 세포의 배양 및 분화가 가능하며 임상적으로도 안전함을 부여할 수 있다. Therefore, in the present invention, since acellular dermis including a basement membrane layer is used, a basement membrane layer that facilitates adhesion of skin-derived cells is included in the structure, and the structure of the dermis is preserved, so additional animal-derived cells No external coating is required. Through this, it is possible to culture and differentiate skin-derived cells on the acellular dermis including the basement membrane layer, and to provide clinical safety.
또한, 본 발명에 따른 기저막층을 포함하는 무세포 진피는 100 내지 300 um의 얇은 두께를 가진다. 따라서, 피부유래 세포의 부착 및 배양 효율을 더욱 향상시킬 수 있으며, 피부 결손부에 이식시 조직이 안전하고 효과적으로 재생될 수 있다.In addition, the acellular dermis including the basement membrane layer according to the present invention has a thin thickness of 100 to 300 um. Therefore, adhesion and culture efficiency of skin-derived cells can be further improved, and tissue can be safely and effectively regenerated when transplanted into a skin defect.
본 발명에서 단계 A) 및 단계 B)는 동물 유래 세포외기질의 코팅 없이 기저막층을 포함하는 무세포 진피 상에 피부유래 세포가 파종될 수 있다. In the present invention, in step A) and step B), skin-derived cells can be seeded on the acellular dermis including the basement membrane layer without coating of the animal-derived extracellular matrix.
또한, 본 발명에서 단계 A) 및 단계 B)는 무영양세포(feeder cell free), 무이종(xeno free) 및 무혈청(serum-free) 배양 요소(환경)에서 수행될 수 있다. 상기 무영양세포(feeder cell free), 무이종(xeno free) 및 무혈청(serum-free) 배양 요소는 피더 세포, 우혈청, 돼지 트립신 등의 동물유래 성분을 포함하지 않는 배지에서 배양 및/또는 분화가 수행되는 것을 의미한다. 이를 통해 외래 동물성 유래 물질의 오염 문제를 해소하여 안전성 있는 인공 피부를 제조할 수 있다. In addition, in the present invention, step A) and step B) may be performed in feeder cell free, xeno free and serum-free culture elements (environment). The feeder cell-free, xeno-free and serum-free culture elements are cultured and/or It means that differentiation is performed. Through this, it is possible to manufacture safe artificial skin by solving the problem of contamination of foreign animal-derived substances.
본 발명에서 단계 A)는 기저막층을 포함하는 무세포 진피의 진피 방향에 섬유아세포를 파종한 후 배양하는 단계이다. In the present invention, step A) is a step of seeding and culturing fibroblasts in the dermal direction of the acellular dermis including the basement membrane layer.
본 발명에서 기저막층을 포함하는 무세포 진피의 진피 방향은 기저막층이 형성되지 않는 진피 방향의 면을 의미하며, 진피층이라고 표현할 수 있다. In the present invention, the dermal direction of the acellular dermis including the basement membrane layer refers to the dermis direction on which the basement membrane layer is not formed, and may be expressed as the dermal layer.
본 발명에서 섬유아세포는 진피의 주된 구성 세포로써, 세포외기질과 성장인자를 분비하여 진피 조직을 더욱 견고하게 할 수 있다.In the present invention, fibroblasts are the main constituent cells of the dermis, and can further strengthen the dermal tissue by secreting the extracellular matrix and growth factors.
일 구체예에서, 파종되는 섬유아세포의 수는 cm
2 당 1X 10
4 내지 1 X 10
6일 수 있다. In one embodiment, the number of fibroblasts to be seeded may be
일 구체예에서, 섬유아세포의 배양은 성장인자 기반의 배양 배지를 사용하여 수행할 수 있으며, 구체적으로 배양 배지는 무이종(xeno free) 및 무혈청(serum-free) 배지일 수 있다. 배양은 1 내지 21일 동안 수행될 수 있다. In one embodiment, culturing of fibroblasts may be performed using a growth factor-based culture medium, and specifically, the culture medium may be a xeno-free and serum-free medium. Cultivation may be performed for 1 to 21 days.
본 발명에서 단계 B)는 기저막층을 포함하는 무세포 진피의 기저막층 상에 각질형성세포를 파종한 후 배양 및 분화하는 단계이다. In the present invention, step B) is a step of seeding keratinocytes on the basement membrane layer of the acellular dermis including the basement membrane layer, followed by culturing and differentiation.
상기 피부각질형성세포는 기저막층을 포함하는 무세포 진피에 부착, 배양 및 분화되어 표피의 역할을 수행할 수 있다. 즉, 본 발명에서는 진피와 표피가 모두 존재하는 전층 인공 피부를 제조할 수 있다. The skin keratinocytes may be adhered to, cultured and differentiated to the acellular dermis including the basement membrane layer to perform the role of the epidermis. That is, in the present invention, it is possible to manufacture a full-thickness artificial skin in which both the dermis and the epidermis exist.
일 구체예에서, 파종되는 각질형성세포의 수는 cm 2 당 5 X 10 4 내지 1 X 10 6일 수 있다.In one embodiment, the number of keratinocytes to be seeded may be 5 X 10 4 to 1 X 10 6 per cm 2 .
일 구체예에서, 각질형성세포의 배양은 당업계에서 일반적으로 사용되는 각질형성세포 배양 배지를 사용하여 수행할 수 있으며, 구체적으로 배양 배지는 성장인자 기반의 무영양세포(feeder cell free), 무이종(xeno free) 및 무혈청(serum-free) 배지일 수 있다. 배양은 1 내지 7일 동안 수행될 수 있다.In one embodiment, the culturing of keratinocytes may be performed using a keratinocyte culture medium generally used in the art, and specifically, the culture medium is a growth factor-based feeder cell free, It can be xeno free and serum-free media. Cultivation can be performed for 1 to 7 days.
또한, 본 발명에서는 각질형성세포를 배양한 후, 7 내지 21 일 동안 분화시킬 수 있다. In addition, in the present invention, after culturing keratinocytes, they can be differentiated for 7 to 21 days.
이때, 분화는 당업계에서 일반적으로 사용되는 각질형성세포 분화 배지를 사용하여 수행될 수 있으며, 구체적으로 분화 배지는 무이종(xeno free) 및 무혈청(serum-free) 배지일 수 있다. In this case, differentiation may be performed using a keratinocyte differentiation medium generally used in the art, and specifically, the differentiation medium may be a xeno-free and serum-free medium.
또한, 본 발명은 전술한 기저막층을 포함하는 진피 기반 인공 피부 제조 방법에 의해 제조된 기저막층을 포함하는 진피 기반 인공 피부에 관한 것이다. In addition, the present invention relates to a dermis-based artificial skin including a basement membrane layer manufactured by the method for manufacturing a dermis-based artificial skin including the basement membrane layer described above.
본 발명에 따른 인공 피부는 섬유아세포를 포함하는 기저막층을 포함하는 무세포 진피; 및The artificial skin according to the present invention comprises: an acellular dermis comprising a basement membrane layer containing fibroblasts; and
상기 기저막층을 포함하는 무세포 진피의 기저막층 상에 형성되며, 각질형성세포가 배양 및 분화된 표피로 구성될 수 있다. It is formed on the basement membrane layer of the acellular dermis including the basement membrane layer, and may be composed of an epidermis in which keratinocytes are cultured and differentiated.
본 발명에 따른 인공 피부는 피부 대체재로서 사용될 수 있으며, 구체적으로, 광범위한 화상, 당뇨병 등으로 인한 피부궤양 또는 피부 손상과 사고, 외상, 노화로 인한 피부조직의 함몰 등에 대한 미용성형 및 재건성형 분야에서 피부 대체재로 사용될 수 있다. The artificial skin according to the present invention can be used as a skin substitute, and specifically, in the field of cosmetic and reconstructive surgery for skin ulcers due to extensive burns, diabetes, etc. or skin damage and accidents, trauma, and depression of skin tissue due to aging. It can be used as a skin substitute.
하기 실시예를 통하여 본 발명을 보다 구체적으로 설명하기로 한다. 그러나, 본 발명의 범주는 하기 실시예에 한정되는 것이 아니며 첨부된 특허청구범위에 기재된 사항에 의해 도출되는 기술적 사항을 벗어나지 않는 범위 내에서 다양한 변형, 수정 또는 응용이 가능하다는 것을 당업자는 이해할 수 있을 것이다. The present invention will be described in more detail through the following examples. However, the scope of the present invention is not limited to the following examples, and it will be understood by those skilled in the art that various changes, modifications or applications are possible within the scope without departing from the technical matters derived from the matters described in the appended claims. will be.
실시예Example
실시예 1. 기저막층을 포함하는 인공 피부 제작Example 1. Fabrication of artificial skin including basement membrane layer
(1) 기저막층을 포함하는 무세포 진피 제조(1) Preparation of acellular dermis including basement membrane layer
피부 조직(조직은행으로부터 비영리 목적의 환자 치료를 위해 기증받은 시신으로부터 채취)을 준비하였다. Skin tissue (collected from a cadaver donated by a tissue bank for non-profit patient care) was prepared.
피부 조직을 더마톰을 이용해, 표피 포함 100 내지 300μm를 절제하여 기저막층을 포함하는 진피를 확보하였다. 그 후 멸균 증류수로 수회 세척하였다.The dermis including the basement membrane layer was obtained by excising 100 to 300 μm including the epidermis from the skin tissue using a dermatom. After that, it was washed several times with sterile distilled water.
절제된 기저막층을 포함하는 진피에 알코올(IPA) 및 헥산(Hexane)의 혼합용액을 처리하여 지방을 제거하고, 표피와 진피에 존재하는 세포를 제거하기 위하여 수산화나트륨(NaOH)을 처리하였다(기저막층 포함 무세포 진피 제조). The dermis including the excised basement membrane layer was treated with a mixed solution of alcohol (IPA) and hexane (Hexane) to remove fat, and sodium hydroxide (NaOH) was treated to remove cells present in the epidermis and dermis (basement membrane layer). inclusion acellular dermis preparation).
기저막층 포함 무세포 진피에 과산화수소(H 2O 2)를 사용하여 피부에 있는 시반을 제거하고 바이러스 불활화를 수행하였다. 세척이 완료된 피부조직은 동결건조를 진행하여 수분을 제거하였고, 멸균하였다.Hydrogen peroxide (H 2 O 2 ) was used in the cell-free dermis including the basement membrane layer to remove the stain on the skin, and virus inactivation was performed. The washed skin tissue was lyophilized to remove moisture and sterilized.
(2) 인공피부 제작(2) Manufacture of artificial skin
기저막층 포함 진피를 배양용기에 넣고 진피층이 위로 오게 위치시킨 다음, 배양액에 부유시킨 섬유아세포를 진피층 방향에 파종 및 배양하여 상기 섬유아세포가 진피층 내로 고착하고 증식되도록 유도하였다. The dermis including the basement membrane layer was placed in a culture vessel and the dermal layer was positioned so that the fibroblasts suspended in the culture medium were seeded and cultured in the dermal layer direction to induce the fibroblasts to adhere and proliferate into the dermal layer.
1~21 일간 배양 후, 섬유아세포가 자라고 있는 무세포 진피의 기저막층을 위로 하도록 뒤집고 각질형성세포를 기저막층 방향에 파종하여 1~7 일간 배양하였다. 그 후, 14 일간 각질형성세포 분화 배지 및 ALI(Air-liquid interface) 상태로 유지하여 분화를 유도하여 인공 피부를 제조하였다.After culturing for 1 to 21 days, the basement membrane layer of the acellular dermis, where fibroblasts are growing, was turned upside down and keratinocytes were seeded in the direction of the basement membrane layer and cultured for 1-7 days. Thereafter, artificial skin was prepared by inducing differentiation by maintaining it in a keratinocyte differentiation medium and an air-liquid interface (ALI) state for 14 days.
비교예 1. 기저막층을 포함하지 않는 인공 피부 제조Comparative Example 1. Preparation of artificial skin without basement membrane layer
(1) 기저막층 포함하지 않는 무세포 진피 제조(1) Preparation of acellular dermis without basement membrane layer
실시예 1의 (1)에서 표피와 기저막층을 제거한 아래로 100 내지 300μm를 절제해 기저막층을 포함하지 않는 진피를 제조한 것을 제외하고는, 실시예의 방법으로 기저막층을 포함하지 않는 무세포 진피를 제조하였다.In Example 1 (1), the epidermis and basement membrane layer were removed and 100 to 300 μm was excised to prepare the dermis not including the basement membrane layer. was prepared.
(2) 인공 피부 제조(2) artificial skin manufacturing
실시예 1의 (2)와 같이 인공 피부를 제조하였다. An artificial skin was prepared as in (2) of Example 1.
본 발명에서 도 1은 얇은 형태의 기저막층을 포함하는 무세포 진피 및 기저막층을 포함하지 않는 무세포 진피를 제작하는 공정을 나타낸다. In the present invention, FIG. 1 shows a process for manufacturing acellular dermis including a thin basement membrane layer and acellular dermis not including a basement membrane layer.
도 1에 나타난 바와 같이, 공여된 피부로부터 표피를 포함하여 100 내지 300 μm를 더마톰으로 절제한 기저막층 포함 진피(실시예 1)와 표피와 기저막층이 제거된 아래로 100 내지 300 μm를 더마톰으로 절제한 기저막층 미포함 진피(비교예 1)를 사용하여, 지방 제거, 탈세포화 및 멸균 등의 공정을 통해 기저막층을 포함하는 무세포 진피 및 기저막층을 포함하지 않는 무세포 진피를 제작하였다.As shown in Fig. 1, the dermis including the basement membrane layer (Example 1), 100 to 300 μm including the epidermis was excised with derma from the donated skin, and 100 to 300 μm from the donor skin, from which the epidermis and basement membrane layer were removed, derma Using the dermis without the basement membrane layer (Comparative Example 1) excised with a tom, the acellular dermis including the basement membrane layer and the acellular dermis not including the basement membrane layer were prepared through processes such as fat removal, decellularization and sterilization. .
이하, 도면에서 기저막 포함 진피는 기저막층을 포함하는 무세포 진피를, 기저막 미포함 진피는 기저막층을 포함하지 않는 무세포 진피를 사용한 경우를 나타낸다. Hereinafter, in the drawings, the dermis including the basement membrane shows a cell-free dermis including the basement membrane layer, and the dermis without the basement membrane uses the acellular dermis not including the basement membrane layer.
실험예 1. 무세포 진피의 두께에 따른 세포 적합성 분석 Experimental Example 1. Analysis of cell compatibility according to the thickness of acellular dermis
기저막층을 포함하는 무세포 진피의 두께에 따른 세포 부착 및 증식을 확인하였다.Cell adhesion and proliferation were confirmed according to the thickness of the acellular dermis including the basement membrane layer.
세척이 완료된 기저막층을 포함하는 무세포 진피를 wet(hydration)한 상태와 동결건조하여 dry한 상태로 1 mm 이하와 2~3 mm 두께로 준비하였다. 이때, 사용된 기저막층을 포함하는 무세포 진피는 두께를 제외하고는 실시예 1의 (1) 방법으로 제조되었다. The cell-free dermis including the basement membrane layer, which had been washed, was prepared in a wet (hydration) state and a dry state by freeze-drying to a thickness of 1 mm or less and 2-3 mm. At this time, the cell-free dermis including the basement membrane layer used was prepared by the method (1) of Example 1 except for the thickness.
상기 기저막층을 포함하는 무세포 진피 위에 cm 2 당 2 X 10 4의 사람 피부유래 섬유아세포(human dermal fibroblast, HDF)를 분사하여 배양하였다. 세포 부착 및 생존을 확인하기 위해, 배양 7일에 CCK-8 Kit로 흡광도를 측정하여 세포 증식 정도를 확인하였다. On the cell-free dermis containing the basement membrane layer, 2 X 10 4 per cm 2 of human dermal fibroblasts (human dermal fibroblasts, HDF) were sprayed and cultured. To check cell adhesion and survival, absorbance was measured with CCK-8 Kit on the 7th day of culture to confirm the degree of cell proliferation.
그 결과를 도 2에 나타내었다. The results are shown in FIG. 2 .
도 2는 두께가 상이한 기저막층을 포함하는 무세포 진피에 피부유래 섬유아세포를 배양하여 세포 증식을 확인한 결과를 나타내는 그래프이다. 상기 도 2에 나타난 바와 같이, 1 mm 이하의 두께를 가지며 동결건조한 제형(dry한 상태)에서 세포 부착과 세포 증식이 매우 우수한 것을 확인할 수 있다.FIG. 2 is a graph showing the results of confirming cell proliferation by culturing skin-derived fibroblasts in acellular dermis including basement membrane layers having different thicknesses. As shown in FIG. 2, it can be confirmed that the cell adhesion and cell proliferation are very excellent in the lyophilized formulation (dry state) having a thickness of 1 mm or less.
실험예 2. 기저막층의 포함 여부에 따른 사람 피부유래 섬유아세포 적합성 분석Experimental Example 2. Analysis of suitability of human skin-derived fibroblasts according to the inclusion of basement membrane layer
(1) 세포 적합성 분석(1) Cell Compatibility Assay
실시예 1의 (1) 및 비교예 1의 (1)에서 제조한 기저막층을 포함하는 무세포 진피(기저막층 포함 진피) 및 기저막층을 포함하지 않는 무세포 진피(기저막층 미포함 진피)에 대한 세포 적합성을 확인하였다. 상기 세포 적합성은 진피 상에 사람 피부유래 섬유아세포를 배양하여 확인하였다. 본 발명에 사용된 모든 세포는 동물유래 성분이 제거된 조건에서 유지 및 배양되었다. Example 1 (1) and Comparative Example 1 (1) prepared in the acellular dermis containing the basement membrane layer (dermis including the basement membrane layer) and the acellular dermis without the basement membrane layer (dermis without the basement membrane layer) Cell compatibility was confirmed. The cell suitability was confirmed by culturing human skin-derived fibroblasts on the dermis. All cells used in the present invention were maintained and cultured under conditions from which animal-derived components were removed.
구체적으로, 실시예 1에서 제조된 기저막층 포함 진피와 비교예 1에서 제조된 기저막층 미포함 진피를 사용하여 세포외기질 성분(CTS, 콜라겐)을 코팅한 상태와 코팅하지 않은 상태에서 cm 2 당 1X10 5의 사람 피부유래 섬유아세포를 포함한 세포혼탁액을 분사하여 배양하였다. 진피 표면에서의 세포 부착 및 증식을 확인하기 위하여, 배양 1일, 4일, 7일, 14일, 21일 동안 세포 배양기에서 배양하였다.Specifically, using the dermis including the basement membrane layer prepared in Example 1 and the dermis without the basement membrane layer prepared in Comparative Example 1, coated and uncoated with extracellular matrix components (CTS, collagen), 1X10 per cm 2 A cell suspension containing 5 human skin-derived fibroblasts was sprayed and cultured. In order to confirm cell adhesion and proliferation on the dermal surface, the cells were cultured in a cell incubator for 1, 4, 7, 14, and 21 days of culture.
세포 적합성 분석은 다음과 같이 진행하였다. 1일, 4일, 7일, 14일, 21일차에 CCK-8 kit로 흡광도를 측정하여 세포 증식 정도를 확인하였다.Cell compatibility analysis was performed as follows. On
세포 적합성 분석 결과를 도 3(a)에 나타내었다. The results of cell compatibility analysis are shown in FIG. 3(a).
도 3(a)는 기저막층의 유무에 따른 기저막층 포함/미포함 진피에서의 섬유아세포의 증식 정도를 확인한 결과를 나타낸다. 상기 도에서 Non coating은 코팅하지 않은 기저막층 포함/미포함 진피, CTS는 세포외기질 성분인 CTS를 코팅한 기저막층 포함/미포함 진피, Collagen은 세포외기질 성분인 콜라겐을 코팅한 기저막층 포함/미포함 진피에서의 흡광도 측정 결과를 나타낸다. Figure 3 (a) shows the results of confirming the degree of proliferation of fibroblasts in the dermis with/without the basement membrane layer according to the presence or absence of the basement membrane layer. In the figure, Non coating is the dermis with/without the uncoated basement membrane layer, CTS is the dermis with/without the basement membrane layer coated with CTS, an extracellular matrix component, and Collagen is the dermis with/without the basement membrane layer coated with the extracellular matrix component, collagen. The results of absorbance measurements in the dermis are shown.
도 3(a)에 나타난 바와 같이, 배양 기간 동안 모든 군에서 섬유아세포의 증식을 확인할 수 있으며, 기저막층 포함 진피가 기저막층 미포함 진피보다 세포 접합성이 우수한 것을 확인할 수 있다. As shown in Fig. 3(a), proliferation of fibroblasts can be confirmed in all groups during the culture period, and it can be confirmed that the dermis with the basement membrane has superior cell adhesion than the dermis without the basement membrane.
(2) 세포 부착 및 세포 생존 분석 (2) Cell adhesion and cell viability assay
또한, 실시예 1의 (1)에서 제조된 기저막층 포함 진피와 비교예 1의 (1)에서 제조된 기저막층 미포함 진피에 사람 피부유래 섬유아세포를 배양하고, 배양 1일, 4일, 7일, 14일, 21일 동안 Live/dead cell viability assay(Life Technology, USA)를 이용하여 세포 부착 및 생존 여부를 공초점 현미경(LSM 700, Carl Zeiss, Germany)으로 확인하였다. In addition, human skin-derived fibroblasts were cultured in the dermis with the basement membrane layer prepared in (1) of Example 1 and the dermis without the basement membrane layer prepared in (1) of Comparative Example 1, and cultured for 1 day, 4 days, 7 days. Cell adhesion and survival were confirmed with a confocal microscope (LSM 700, Carl Zeiss, Germany) using Live/dead cell viability assay (Life Technology, USA) for 14 days and 21 days.
세포 부착 및 세포 생존을 도 3(b) 및 (c)에 나타내었다. Cell adhesion and cell viability are shown in FIGS. 3(b) and (c).
도 3(b) 및 (c)는 기저막층 포함 진피(B) 및 기저막층 미포함 진피(C)에 섬유아세포를 배양하여 기간별로 세포 생존(구체적으로, 세포 부착 및 세포 증식)을 확인한 결과를 나타낸다. 7일 이후에는 파종된 면과 반대쪽 면을 모두 관찰하였으며, 초록색은 살아있는 세포를, 빨간색은 사멸한 세포를 나타낸다.3 (b) and (c) show the results of confirming cell survival (specifically, cell adhesion and cell proliferation) by culturing fibroblasts in the dermis with the basement membrane layer (B) and the dermis without the basement membrane layer (C) . After 7 days, both the seeded side and the opposite side were observed. Green indicates live cells and red indicates dead cells.
상기 도 3(b)에 나타난 바와 같이, 기저막층 포함 진피 및 기저막층 미포함 진피 모두에서 세포 증식이 활발한 것을 확인할 수 있다. 특히, 기저막층 포함 진피의 경우, 7일 이후부터 세포가 분사된 반대 방향에서도 세포가 증식된 것을 확인할 수 있다.As shown in FIG. 3(b) , it can be confirmed that cell proliferation is active in both the dermis including the basement membrane layer and the dermis without the basement membrane layer. In particular, in the case of the dermis including the basement membrane layer, it can be seen that the cells proliferated in the opposite direction from which the cells were sprayed after 7 days.
실험예 3. 기저막층의 포함 여부에 따른 사람 피부유래 각질형성세포 적합성 분석Experimental Example 3. Analysis of compatibility of human skin-derived keratinocytes according to the presence or absence of basement membrane layer
(1) 세포 적합성 분석(1) Cell Compatibility Assay
실시예 1의 (1) 및 비교예 1의 (1)에서 제조한 기저막층 포함/미포함 진피에 대한 세포 적합성을 확인하였다. 상기 세포 적합성은 기저막층 포함/미포함 진피 상에 사람 피부유래 각질형성세포(human keratinocytes, HEK)를 배양하여 확인하였다.Cell compatibility for the dermis with/without the basement membrane layer prepared in Example 1 (1) and Comparative Example 1 (1) was confirmed. The cell suitability was confirmed by culturing human skin-derived keratinocytes (HEK) on the dermis with/without the basement membrane layer.
구체적으로, 기저막층 포함 진피와 기저막층 미포함 진피을 사용하여 세포외기질 성분(CTS, 콜라겐)을 코팅한 상태와 코팅하지 않은 상태에서 cm 2 당 1X10 5의 각질형성세포를 포함한 세포혼탁액을 분사하여 배양하였다. 진피 표면에서의 세포 부착 및 증식을 확인하기 위하여, 일정 기간 동안 세포 배양기에서 배양하였다.Specifically, using the dermis with the basement membrane layer and the dermis without the basement membrane layer, the cell suspension containing 1X10 5 keratinocytes per cm 2 is sprayed with and without the extracellular matrix component (CTS, collagen) coated. cultured. In order to confirm cell adhesion and proliferation on the dermal surface, the cells were cultured in a cell culture medium for a certain period of time.
세포 적합성 분석은 다음과 같이 진행하였다. 1일, 3일, 7일차에 CCK-8 kit로 흡광도를 측정하여 세포 증식 정도를 확인하였다Cell compatibility analysis was performed as follows. On the 1st, 3rd, and 7th days, the absorbance was measured with the CCK-8 kit to confirm the degree of cell proliferation.
세포 적합성 분석 결과를 도 4(a)에 나타내었다. The results of cell compatibility analysis are shown in FIG. 4(a).
도 4(a)는 기저막층의 유무에 따른 기저막층 포함/미포함 진피에서의 각질형성세포의 증식 정도를 확인한 결과를 나타낸다. 상기 도에서 Non coating은 기저막층 포함/미포함 진피를 코팅하지 않은 상태, CTS는 세포외기질 성분인 CTS를 코팅한 상태, Collagen은 세포외기질 성분인 콜라겐을 코팅한 상태에서의 흡광도 측정 결과를 나타낸다. 4(a) shows the results of confirming the proliferation degree of keratinocytes in the dermis with/without the basement membrane layer according to the presence or absence of the basement membrane layer. In the figure, Non coating shows the absorbance measurement results in a state in which the dermis with/without basement membrane layer is not coated, CTS is in a state in which CTS, an extracellular matrix component, is coated, and Collagen is in a state in which collagen, an extracellular matrix component, is coated. .
도 4(a)에 나타난 바와 같이, 배양 기간 동안 기저막층 포함 진피는 코팅 여부에 관계없이 세포가 증식하였으나, 기저막층 미포함 진피는 시간에 따라 흡광도가 감소하여 세포가 사멸됨을 확인할 수 있다.As shown in Fig. 4(a), cells proliferated in the dermis including the basement membrane during the culture period regardless of whether or not the coating was applied, but in the dermis without the basement membrane layer, the absorbance decreased over time, thereby causing cell death.
(2) 세포 부착 및 세포 생존 분석 (2) Cell adhesion and cell viability assay
또한, 실시예 1에서 제조된 기저막층 포함 진피에 각질형성세포를 배양하고, 배양 1일, 4일, 7일차에 Live/dead cell viability assay(Life Technology, USA)를 이용하여 세포 부착 및 생존 여부를 공초점 현미경(LSM 700, Carl Zeiss, Germany)으로 확인하였다.In addition, keratinocytes were cultured in the dermis including the basement membrane layer prepared in Example 1, and cell adhesion and survival were observed using Live/dead cell viability assay (Life Technology, USA) on the 1st, 4th, and 7th days of culture. was confirmed with a confocal microscope (LSM 700, Carl Zeiss, Germany).
본 실험예에서는 기저막층 포함 진피를 코팅하지 않거나 또는 세포외기질(CTS, 콜라겐)로 코팅하여 사용하였다. In this experimental example, the dermis including the basement membrane was not coated or coated with an extracellular matrix (CTS, collagen).
세포 부착 및 세포 생존을 도 4(b)에 나타내었다. Cell adhesion and cell viability are shown in Fig. 4(b).
도 4(b)는 기저막층을 포함 진피에 각질형성세포를 배양하여 기간별로 세포 생존(구체적으로, 세포 부착 및 세포 증식)을 확인한 결과를 나타낸다. 상기 도 4(b)에서 초록색은 살아있는 세포를, 빨간색은 사멸한 세포를 나타낸다.Figure 4(b) shows the results of confirming cell survival (specifically, cell adhesion and cell proliferation) by period by culturing keratinocytes in the dermis including the basement membrane layer. In FIG. 4(b), green indicates living cells and red indicates dead cells.
도 4(b)에 나타난 바와 같이, 미코팅된 기저막층 포함 진피에 분사된 각질형성세포의 시간에 따른 증식율이 코팅한 인공 피부 지지체 대비 우수한 것을 확인할 수 있다.As shown in FIG. 4( b ), it can be confirmed that the proliferation rate of keratinocytes injected into the dermis including the uncoated basement membrane over time is superior to that of the coated artificial skin support.
(3) 각질형성세포 수에 따른 세포 부착 및 증식의 차이 분석(3) Analysis of differences in cell adhesion and proliferation according to the number of keratinocytes
또한, 각질형성세포 수에 따른 세포 부착 및 증식의 차이를 확인하기 위해, 실시예 1의 (1)에서 제조된 기저막층 포함 진피 위에 cm
2 당 1 내지 3 X 10
5의 각질형성세포를 포함한 세포혼탁액을 분사하여 배양하였다. 배양 1일과 3일차에 Live/dead cell viability assay(Life Technology, USA)를 이용하여 세포 부착 및 생존 여부를 공초점 현미경(LSM 700, Carl Zeiss, Germany)으로 확인하였다.In addition, in order to confirm the difference in cell adhesion and proliferation according to the number of keratinocytes, cells containing 1 to 3
각질형성세포 수에 따른 세포 부착 및 증식 결과를 도 4(c)에 나타내었다. The results of cell adhesion and proliferation according to the number of keratinocytes are shown in FIG. 4(c).
도 4(c)는 기저막층 포함 진피에 각질형성세포의 수를 다르게 파종하여 배양하고 기간별 세포 생존을 확인한 결과를 나타낸다. 이때, 초록색은 살아있는 세포를, 빨간색은 사멸한 세포를 나타낸다.4( c ) shows the results of seeding and culturing different numbers of keratinocytes in the dermis including the basement membrane layer and confirming the cell survival for each period. In this case, green indicates living cells and red indicates dead cells.
도 4(c)에 나타난 바와 같이, 기저막층 포함 진피에서 세포 수에 따라 각질형성 세포가 증식됨을 확인할 수 있다.As shown in FIG. 4(c), it can be confirmed that keratinocytes proliferate according to the number of cells in the dermis including the basement membrane layer.
상기 도 3 및 4를 통해 기저막층 포함 진피가 피부유래 세포와 적합성 및 친화성이 있음을 확인할 수 있다.3 and 4, it can be confirmed that the dermis including the basement membrane has compatibility and affinity with skin-derived cells.
실험예 4. 기저막층 포함 진피의 인공 피부로서의 적합성 분석Experimental Example 4. Analysis of suitability of dermis including basement membrane as artificial skin
실시예 1의 (1)에서 제조된 기저막층 포함 진피를 사용하여, 진피 방향에 초록색을 나타내는 DiO를 표지한 섬유아세포를 파종하여 배양하고, 기저막층 위에 빨간색을 나타내는 DiI로 표지한 각질형성세포를 파종한 뒤 배양하고, 배양 1일 후 세포 부착 및 형태를 확인하였다.Using the dermis including the basement membrane layer prepared in Example 1 (1), fibroblasts labeled with DiO in the direction of the dermis were seeded and cultured, and keratinocytes labeled with DiI indicating red on the basement membrane layer were harvested. After seeding, culture was performed, and cell adhesion and morphology were confirmed after 1 day of culture.
세포 부착 및 형태를 확인할 결과를 도 5에 나타내었다. The results of confirming cell adhesion and morphology are shown in FIG. 5 .
도 5에 나타난 바와 같이, 각질형성세포 및 섬유아세포 모두 기저막층 포함 진피층에 부착하여 증식한 것을 확인할 수 있다. As shown in FIG. 5 , it can be confirmed that both keratinocytes and fibroblasts adhere to and proliferate in the dermal layer including the basement membrane layer.
또한, 각질형성세포 부분을 ALI(air liquid interface)를 통해 분화 유도하였다.In addition, differentiation of keratinocytes was induced through an air liquid interface (ALI).
구체적으로, 기저막층 포함 진피의 진피층 위에 섬유아세포를 배양한 후, 각질형성세포를 기저막층 방향에 파종하여 배양한 다음, 14 일간 각질형성세포 분화 배지 및 ALI(Air-liquid interface) 상태로 유지하여 분화를 유도하였다. 이를 통해 인공 피부를 제조하였다. Specifically, after culturing fibroblasts on the dermal layer of the dermis including the basement membrane layer, keratinocytes were seeded in the direction of the basement membrane layer and cultured, and then maintained in a keratinocyte differentiation medium and ALI (air-liquid interface) state for 14 days. differentiation was induced. Through this, artificial skin was manufactured.
도 6은 조직학적 분석을 통한 분화 결과를 나타낸다. 피부 유래 세포들이 파종 후 증식하여 14일간 분화 유도된 인공 피부를 중성화 포르말린으로 고정한 뒤, 동결박절하여 Hematoxylin & Eosin(H&E) 염색으로 표본 전체를 관찰하였다. 6 shows the differentiation results through histological analysis. The skin-derived cells proliferated after seeding, and the differentiation-induced artificial skin was fixed with neutralized formalin for 14 days, frozen and sliced, and the entire specimen was observed with Hematoxylin & Eosin (H&E) staining.
도 6을 통해, 기저막층 포함 진피에서 각질형성세포가 분화된 인공 피부를 확인할 수 있다.6 , it can be confirmed that artificial skin in which keratinocytes are differentiated from the dermis including the basement membrane layer is identified.
인공 피부 지지체 상에 피부유래 세포를 배양하여 제조한 인공 피부는 피부 결손부에 이식 시 조직이 안전하고 효과적으로 재생될 수 있다.Artificial skin prepared by culturing skin-derived cells on an artificial skin support can safely and effectively regenerate tissue when transplanted into a skin defect.
Claims (11)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2020/018666 WO2022131407A1 (en) | 2020-12-18 | 2020-12-18 | Dermis-based artificial skin comprising basement membrane layer and manufacturing method therefor |
| CN202080049912.1A CN114980939A (en) | 2020-12-18 | 2020-12-18 | Artificial skin based on dermis containing substrate film layer and manufacturing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2020/018666 WO2022131407A1 (en) | 2020-12-18 | 2020-12-18 | Dermis-based artificial skin comprising basement membrane layer and manufacturing method therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022131407A1 true WO2022131407A1 (en) | 2022-06-23 |
Family
ID=82057692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2020/018666 Ceased WO2022131407A1 (en) | 2020-12-18 | 2020-12-18 | Dermis-based artificial skin comprising basement membrane layer and manufacturing method therefor |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN114980939A (en) |
| WO (1) | WO2022131407A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116870259B (en) * | 2023-07-13 | 2025-08-22 | 济南磐升生物技术有限公司 | Artificial skin containing basement membrane and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050186286A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshihiro Takami | Skin decellularization method, acellular dermal matrix and production method therefore employing said decellularization method, and composite cultured skin employing said matrix |
| KR20110027880A (en) * | 2009-09-11 | 2011-03-17 | 한림대학교 산학협력단 | Methods for preparing cryopreserved acellular dermal substrates and cryopreserved acellular dermal substrates prepared therefrom |
| US8067149B2 (en) * | 1990-09-12 | 2011-11-29 | Lifecell Corporation | Acellular dermal matrix and method of use thereof for grafting |
| WO2013137664A1 (en) * | 2012-03-15 | 2013-09-19 | 주식회사 엘앤씨바이오 | Cell-free dermal tissue implant |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1224429C (en) * | 2002-12-04 | 2005-10-26 | 曹谊林 | Tissue engineering artificial skin constructed on the rack of heterogenous or xenogenous bone matrix gelatin |
| CN1737129B (en) * | 2004-08-19 | 2010-10-06 | 丘纪屏 | Artificial skin graft and preparation method thereof |
-
2020
- 2020-12-18 CN CN202080049912.1A patent/CN114980939A/en active Pending
- 2020-12-18 WO PCT/KR2020/018666 patent/WO2022131407A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067149B2 (en) * | 1990-09-12 | 2011-11-29 | Lifecell Corporation | Acellular dermal matrix and method of use thereof for grafting |
| US20050186286A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshihiro Takami | Skin decellularization method, acellular dermal matrix and production method therefore employing said decellularization method, and composite cultured skin employing said matrix |
| KR20110027880A (en) * | 2009-09-11 | 2011-03-17 | 한림대학교 산학협력단 | Methods for preparing cryopreserved acellular dermal substrates and cryopreserved acellular dermal substrates prepared therefrom |
| WO2013137664A1 (en) * | 2012-03-15 | 2013-09-19 | 주식회사 엘앤씨바이오 | Cell-free dermal tissue implant |
Non-Patent Citations (3)
| Title |
|---|
| BEAUDOIN CLOUTIER CHANEL, GUIGNARD RINA, BERNARD GENEVIÈVE, GAUVIN ROBERT, LAROUCHE DANIELLE, LAVOIE AMÉLIE, LACROIX DAN, MOULIN V: "Production of a Bilayered Self-Assembled Skin Substitute Using a Tissue-Engineered Acellular Dermal Matrix", TISSUE ENGINEERING. PART C, vol. 21, no. 12, 1 December 2015 (2015-12-01), US , pages 1297 - 1305, XP055942813, ISSN: 1937-3384, DOI: 10.1089/ten.tec.2015.0258 * |
| DUSSOYER MÉLISSA, MICHOPOULOU ANNA, ROUSSELLE PATRICIA: "Decellularized Scaffolds for Skin Repair and Regeneration", APPLIED SCIENCES, vol. 10, no. 10, pages 1 - 24, XP055942825, DOI: 10.3390/app10103435 * |
| KUMAR SHUKLA ARVIND, ARVINDSHUKLA, NIGAMANANDADEY: "Annals of Public Health and Research AcellularDermisasaDermal MatrixofTissueEngineered SkinSubstituteforBurns Treatment", ANNALS OF PUBLIC HEALTH AND RESEARCH, vol. 2, no. 3, 1 January 2015 (2015-01-01), pages 1 - 17, XP055942818 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114980939A (en) | 2022-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Márquez et al. | Decellularization of bovine corneas for tissue engineering applications | |
| Mansbridge | Skin substitutes to enhance wound healing | |
| US6699287B2 (en) | Dermal scaffold using alkaline pre-treated chitosan matrix or alkaline pre-treated chitosan and alkaline pre-treated collagen mixed matrix | |
| EP2412795B1 (en) | Crosslinked material comprising elastin and collagen, and use thereof | |
| EP1115432B1 (en) | Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge | |
| WO2017074093A1 (en) | Wound dressing material comprising fibrillated acellular dermis matrix and biodegradable polymer, and preparation method therefor | |
| WO2022014769A1 (en) | Hydrated acellular skin substitute and manufacturing method therefor | |
| WO2016006944A1 (en) | Method for making three-dimensional cultured skin model including dermis and epidermis, and three-dimensional cultured skin model made thereby | |
| WO2020067774A1 (en) | Synovium-derived mesenchymal stem cells and use thereof | |
| WO2013137664A1 (en) | Cell-free dermal tissue implant | |
| WO2018117569A1 (en) | Multilayer cardiac stem cell sheet and method for manufacturing same | |
| WO2020111868A1 (en) | Bio-ink composition for 3d printing, containing human-derived component and having tissue-specific cell differentiation effect, and preparation method therefor | |
| WO2021162530A1 (en) | Decellularized heart extracellular matrix-derived scaffold for culturing and transplanting heart organoid, and preparation method therefor | |
| WO2020056815A1 (en) | Artificial dermis repair material and preparation method therefor | |
| WO2022131407A1 (en) | Dermis-based artificial skin comprising basement membrane layer and manufacturing method therefor | |
| WO2021117915A1 (en) | Scaffold using adipose tissue-derived extracellular matrix, and method for producing same | |
| KR20220087890A (en) | Dermal-based artificial skin comprising a basement membrane layer and method for manufacturing the same | |
| WO2021101198A2 (en) | Injectable hydrogel composition capable of capturing endogenous progenitor cells or stem cells, and inducing vascular differentiation of captured cells | |
| WO2021125373A1 (en) | Medical composition comprising adipose tissue-derived extracellular matrix and method for preparing same | |
| WO2022108314A1 (en) | Pancreatic extracellular matrix-derived support for pancreatic organoid culture and transplantation, and method for preparing same | |
| WO2022158816A1 (en) | Filler composition for reducing skin wrinkles comprising stem cell-derived exosomes, hyaluronic acid, and bdde and method for preparing same | |
| WO2024014795A1 (en) | Extracellular matrix-based hydrogel and sponge for wound healing or tissue regeneration, and production method therefor | |
| WO2020190094A1 (en) | Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same | |
| WO2024111884A1 (en) | Anti-adhesion coating composition for promoting tissue regeneration | |
| WO2025116107A1 (en) | Composition for preparing acellular allogeneic dermis, and method for preparing acellular allogeneic dermis by using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20966061 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 20966061 Country of ref document: EP Kind code of ref document: A1 |